Atea Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -104 | -2,419 | -3,440 | |
EBITDA | -54,830 | -41,749 | -41,319 | -38,937 |
EBIT | -54,934 | -41,853 | -41,423 | -39,041 |
Net Income | -44,867 | -42,049 | -37,161 | -34,272 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -28,223 | -40,375 | -32,870 | -30,563 |
Cash | 95,713 | 77,344 | 87,721 | 119,394 |
Basic Shares | 78,126 | 79,052 | 83,747 | 85,159 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $192,180 |
Gross Profit | -416 | -83,367 | -70,090 | -260 |
EBITDA | -180,887 | -131,800 | -119,593 | -130,390 |
EBIT | -181,303 | -132,216 | -120,009 | -130,650 |
Net Income | -158,349 | -168,385 | -135,956 | -115,909 |
Net Change In Cash | 0 | 0 | 0 | 192,180 |
Free Cash Flow | -132,031 | -135,499 | -85,395 | -122,925 |
Cash | 95,713 | 64,696 | 143,823 | 646,709 |
Basic Shares | 81,495 | 84,264 | 83,389 | 83,245 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.57 |
2025-09-30 | -$0.53 |
2025-06-30 | -$0.44 |
2025-03-31 | -$0.40 |
